Schedule 13G ownership disclosure
SYROS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 87184Q206
Event date: 2023-01-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,253,828
- Percent of class
- 6.0400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-000691
- Form type
- SC 13G
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Jan 25, 2023
- Reporting period
- Jan 15, 2023
- Description
- Schedule 13G beneficial ownership